Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical interpretation of recurrence data.

T E Bynum

    Journal of Clinical Gastroenterology
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Maintenance therapy can prevent peptic ulcer disease recurrence, especially in the first year post-healing. Patients over 50 or high-risk individuals benefit most from this treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of histamine on haemorrhagic mucosal lesions is related to vascular permeability in rats: studies with histamine, H1-, H2- and H3-agonists and bradykinin.

    European journal of gastroenterology & hepatology·1995
    Same author

    Lung damage aggravates gastric mucosal lesions induced by ethanol in the rat.

    Digestion·1995
    Same author

    "Endemic" idiopathic portal hypertension: report on 32 patients with non-cirrhotic portal fibrosis.

    World journal of surgery·1992
    Same author

    Clinical aspects of gastroduodenal ulcer recurrence: an overview.

    Scandinavian journal of gastroenterology. Supplement·1992
    Same author

    Maintenance therapy with sucralfate in duodenal ulcer: genuine prevention or accelerated healing of ulcer recurrence?

    The American journal of medicine·1991
    Same author

    Practice patterns and costs of hospitalization for upper gastrointestinal hemorrhage.

    Journal of clinical gastroenterology·1991
    Same journal

    GLP-1 Receptor Agonists and Hepatic Encephalopathy in Cirrhosis: A Protective Signal Requiring Cancer and Nutritional Phenotyping.

    Journal of clinical gastroenterology·2026
    Same journal

    Endoscopic Incisional Therapy for Benign Esophageal Strictures: A Systematic Review and Meta-Analysis.

    Journal of clinical gastroenterology·2026
    Same journal

    International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

    Journal of clinical gastroenterology·2026
    Same journal

    Do Risk Factors for Reflux Symptoms After Peroral Endoscopic Myotomy Necessarily Increase the Occurrence of Postoperative Gastroesophageal Reflux?

    Journal of clinical gastroenterology·2026
    Same journal

    Subgroup Stratification by Regimen, Geography, and Population Is Necessary to Validate Nitazoxanide-based Helicobacter pylori Eradication Therapy.

    Journal of clinical gastroenterology·2026
    Same journal

    The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System.

    Journal of clinical gastroenterology·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Peptic ulcer disease (PUD) frequently recurs after initial treatment.
    • Recurrence poses significant risks, particularly during the first year post-healing.

    Purpose of the Study:

    • To evaluate the efficacy of maintenance drug therapy for preventing peptic ulcer disease recurrence.
    • To identify optimal candidates and agents for long-term PUD management.

    Main Methods:

    • Review of existing studies on peptic ulcer disease recurrence and maintenance therapy.
    • Analysis of risk factors for PUD relapse and serious complications.

    Main Results:

    • Maintenance therapy significantly reduces PUD recurrence rates.
    • Patients over 50 and those with risk factors (smoking, family history, prior relapse) are prime candidates.

    Related Experiment Videos

  • Sucralfate is identified as a potentially suitable agent due to its local action, low toxicity, and effectiveness.

    • Conclusions:

    • Maintenance therapy is recommended for PUD patients, especially within the first year of healing.
    • Risk stratification is crucial for identifying patients who will benefit most from long-term treatment.
    • Sucralfate presents a favorable option for PUD maintenance therapy.